Serum immunoglobulin G antibody titer to Fusobacterium nucleatum is associated with unfavorable outcome after stroke. 2020

H Nishi, and N Hosomi, and K Ohta, and S Aoki, and M Nakamori, and T Nezu, and H Shigeishi, and T Shintani, and T Obayashi, and K Ishikawa, and N Kinoshita, and Y Shiga, and M Sugiyama, and H Ohge, and H Maruyama, and H Kawaguchi, and H Kurihara
Department of General Dentistry, Hiroshima University Hospital, Hiroshima, Japan.

Stroke can be a cause of death, while in non-fatal cases it is a common cause of various disabilities resulting from associated brain damage. However, whether a specific periodontal pathogen is associated with increased risk of unfavorable outcome after stroke remains unknown. We examined risk factors for unfavorable outcome following stroke occurrence, including serum antibody titers to periodontal pathogens. The enrolled cohort included 534 patients who had experienced an acute stroke, who were divided into favorable (n = 337) and unfavorable (n = 197) outcome groups according to modified ranking scale (mRS) score determined at 3 months after onset (favorable = score 0 or 1; unfavorable = score 2-6). The associations of risk factors with unfavorable outcome, including serum titers of IgG antibodies to 16 periodontal pathogens, were examined. Logistic regression analysis showed that the initial National Institutes of Health stroke scale score [odds ratio (OR) = 1·24, 95% confidence interval (CI) = 1·18-1·31, P < 0·001] and C-reactive protein (OR = 1·29, 95% CI = 1·10-1·51, P = 0·002) were independently associated with unfavorable outcome after stroke. Following adjustment with those, detection of the antibody for Fusobacterium nucleatum ATCC 10953 in serum remained an independent predictor of unfavorable outcome (OR = 3·12, 95% CI = 1·55-6·29, P = 0·002). Determination of the antibody titer to F. nucleatum ATCC 10953 in serum may be useful as a predictor of unfavorable outcome after stroke.

UI MeSH Term Description Entries
D007074 Immunoglobulin G The major immunoglobulin isotype class in normal human serum. There are several isotype subclasses of IgG, for example, IgG1, IgG2A, and IgG2B. Gamma Globulin, 7S,IgG,IgG Antibody,Allerglobuline,IgG(T),IgG1,IgG2,IgG2A,IgG2B,IgG3,IgG4,Immunoglobulin GT,Polyglobin,7S Gamma Globulin,Antibody, IgG,GT, Immunoglobulin
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011237 Predictive Value of Tests In screening and diagnostic tests, the probability that a person with a positive test is a true positive (i.e., has the disease), is referred to as the predictive value of a positive test; whereas, the predictive value of a negative test is the probability that the person with a negative test does not have the disease. Predictive value is related to the sensitivity and specificity of the test. Negative Predictive Value,Positive Predictive Value,Predictive Value Of Test,Predictive Values Of Tests,Negative Predictive Values,Positive Predictive Values,Predictive Value, Negative,Predictive Value, Positive
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D000369 Aged, 80 and over Persons 80 years of age and older. Oldest Old
D000907 Antibodies, Bacterial Immunoglobulins produced in a response to BACTERIAL ANTIGENS. Bacterial Antibodies
D012307 Risk Factors An aspect of personal behavior or lifestyle, environmental exposure, inborn or inherited characteristic, which, based on epidemiological evidence, is known to be associated with a health-related condition considered important to prevent. Health Correlates,Risk Factor Scores,Risk Scores,Social Risk Factors,Population at Risk,Populations at Risk,Correlates, Health,Factor, Risk,Factor, Social Risk,Factors, Social Risk,Risk Factor,Risk Factor Score,Risk Factor, Social,Risk Factors, Social,Risk Score,Score, Risk,Score, Risk Factor,Social Risk Factor

Related Publications

H Nishi, and N Hosomi, and K Ohta, and S Aoki, and M Nakamori, and T Nezu, and H Shigeishi, and T Shintani, and T Obayashi, and K Ishikawa, and N Kinoshita, and Y Shiga, and M Sugiyama, and H Ohge, and H Maruyama, and H Kawaguchi, and H Kurihara
December 2003, Seminars in thrombosis and hemostasis,
H Nishi, and N Hosomi, and K Ohta, and S Aoki, and M Nakamori, and T Nezu, and H Shigeishi, and T Shintani, and T Obayashi, and K Ishikawa, and N Kinoshita, and Y Shiga, and M Sugiyama, and H Ohge, and H Maruyama, and H Kawaguchi, and H Kurihara
April 2000, Oral microbiology and immunology,
H Nishi, and N Hosomi, and K Ohta, and S Aoki, and M Nakamori, and T Nezu, and H Shigeishi, and T Shintani, and T Obayashi, and K Ishikawa, and N Kinoshita, and Y Shiga, and M Sugiyama, and H Ohge, and H Maruyama, and H Kawaguchi, and H Kurihara
July 1981, Journal of clinical microbiology,
H Nishi, and N Hosomi, and K Ohta, and S Aoki, and M Nakamori, and T Nezu, and H Shigeishi, and T Shintani, and T Obayashi, and K Ishikawa, and N Kinoshita, and Y Shiga, and M Sugiyama, and H Ohge, and H Maruyama, and H Kawaguchi, and H Kurihara
June 1993, Oral microbiology and immunology,
H Nishi, and N Hosomi, and K Ohta, and S Aoki, and M Nakamori, and T Nezu, and H Shigeishi, and T Shintani, and T Obayashi, and K Ishikawa, and N Kinoshita, and Y Shiga, and M Sugiyama, and H Ohge, and H Maruyama, and H Kawaguchi, and H Kurihara
June 1992, Infection and immunity,
H Nishi, and N Hosomi, and K Ohta, and S Aoki, and M Nakamori, and T Nezu, and H Shigeishi, and T Shintani, and T Obayashi, and K Ishikawa, and N Kinoshita, and Y Shiga, and M Sugiyama, and H Ohge, and H Maruyama, and H Kawaguchi, and H Kurihara
January 1981, Archives of oral biology,
H Nishi, and N Hosomi, and K Ohta, and S Aoki, and M Nakamori, and T Nezu, and H Shigeishi, and T Shintani, and T Obayashi, and K Ishikawa, and N Kinoshita, and Y Shiga, and M Sugiyama, and H Ohge, and H Maruyama, and H Kawaguchi, and H Kurihara
November 1988, Advances in dental research,
H Nishi, and N Hosomi, and K Ohta, and S Aoki, and M Nakamori, and T Nezu, and H Shigeishi, and T Shintani, and T Obayashi, and K Ishikawa, and N Kinoshita, and Y Shiga, and M Sugiyama, and H Ohge, and H Maruyama, and H Kawaguchi, and H Kurihara
April 2003, Oral microbiology and immunology,
H Nishi, and N Hosomi, and K Ohta, and S Aoki, and M Nakamori, and T Nezu, and H Shigeishi, and T Shintani, and T Obayashi, and K Ishikawa, and N Kinoshita, and Y Shiga, and M Sugiyama, and H Ohge, and H Maruyama, and H Kawaguchi, and H Kurihara
July 1989, Journal of veterinary diagnostic investigation : official publication of the American Association of Veterinary Laboratory Diagnosticians, Inc,
H Nishi, and N Hosomi, and K Ohta, and S Aoki, and M Nakamori, and T Nezu, and H Shigeishi, and T Shintani, and T Obayashi, and K Ishikawa, and N Kinoshita, and Y Shiga, and M Sugiyama, and H Ohge, and H Maruyama, and H Kawaguchi, and H Kurihara
March 2015, Infectious diseases (London, England),
Copied contents to your clipboard!